ReviewInternational journal of molecular sciences2023

The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.

Rafael Coveñas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.